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Abstract 
In Crohn's disease natural history, about 80% of the patients require surgery, which is not 
curative: unfortunately, the disease recurs in many patients. 
Objective: To investigate the role of intestinal ultrasound to predict the risk of post-operative 
surgical recurrence in Crohn’s disease. 
Material and methods: 196 patients, with ileal or ileocolonic Crohn’s disease, undergoing 
intestinal resection, were retrospectively enrolled. All patients underwent bowel ultrasonography 
6–15 months after resection. Wall thickness at the anastomosis level was measured, and 
thickening > 3[mm] was evaluated as risk factor of long-term need for reoperation. 
Results: Patients who have a bowel wall thickness > 3[mm] have a RR of surgical recurrence = 
2.1 (95% CI = 1.12 – 3.74) higher than those with a thickness of ≤ 3[mm]. The absolute 
incidence of new surgical intervention is 13% in patients with thickness of 3[mm], 28% in 
patients with thickness > 3[mm], 29,1% with thickness > 4[mm], 34% with thickness > 5[mm], 
40% with thickness > 6[mm]. 
Conclusions: Bowel wall thickness > 3[mm] at ultrasound may be a non-invasive predictor of 
early surgical recurrence after ileo-colonic resection. 
Key words: Bowel ultrasonography; Crohn’s disease; Post-surgical recurrence. 
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1. Introduction 
 
About 80% of the patients with Crohn's disease require surgery [1]. 
Smoking, prior bowel surgery, penetrating disease behavior, perianal location, 
extended resection of the small intestine, no prophylactic treatment are 
predictors of early recurrence after ileo-colonic resection [1]. 
Endoscopic recurrence predicts clinical recurrence and severe 
endoscopic recurrence predicts poor prognosis [2]. None invasive examinations 
include [3]: wireless capsule endoscopy that, after excluding stricture, seems 
accurate in small series, but no validated score is available; CT enteroclysis, but 
ionising radiation exposure limits its use; MR that may be as powerful as 
ileocolonoscopy in diagnosing postoperative recurrence and in predicting the 
clinical outcome.  
Many studies show that bowel ultrasonography is valuable for predicting 
the risk of surgical intervention in patients never surgically treated [4,5], and for 
identifying post-surgical recurrence (Fig. 1) [6-10].  
 
Fig. 1. 
 
Only one study considers bowel ultrasound as a predictor of post-surgical 
recurrence in patients treated with conservative surgery (strictureplasty) [11]. 
 
2. Methods 
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We performed a retrospective study on 196 patients that underwent ileal or ileo-
colonic resection with ileo-colonic anastomosis between December 1993 and 
March 2009 (all diagnosis of Crohn’s disease was confirmed at histologic 
examination). All patients underwent bowel ultrasound after at least 6 months 
from surgery.  
The study was reviewed and authorized by Local Ethical Committee. 
Bowel ultrasound was performed in these years with the following 
ultrasonographic equipments: ESAOTE AU4, ESAOTE Technos, ESAOTE My 
Lab 70, TOSHIBA Aplio . A first evaluation of the bowel was made with a 
convex transducer (frequency 3.5[MHz]) and then with a high frequency linear-
array transducer (7.5–10[MHz]). 
The 4 ultrasonographers who performed the examinations were all radiologists 
having at least 3 years’ experience in ultrasound scanning of patients with 
intestinal bowel diseases and working in the same department. Each 
investigation was performed by one radiologist, C. T., S. A, R. D., D. P., that 
respectively performed 69, 55, 39 and 33 investigations. During the procedure 
the involved tract wall was examined in a transverse section, from the central 
hyperechoic line of the lumen to the outer hyperechoic margin of the wall with a 
linear-array transducer. Wall thickness of the ileo-colonic anastomosis was 
calculated as the average of at least 3 measurements; at the end of the US 
investigation measurements of intestinal wall at the level of ileo-colonic 
anastomosis were reported on a standardized form. 
Ileocolonoscopy was performed in a little percentage of patients and in 
different time respect to bowel ultrasound because of the invasiveness of a 
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colonoscopy in patients that underwent resection for Crohn disease of the 
ileum, so is impossible to prove any correlation. 
The CDAI was calculated in the follow up visits. 
Bowel wall thickness (whose normal value is ≤ 3[mm] [12]) was evaluated as a 
predictor of surgical recurrence: we assumed a wall thickness at the 
anastomosis level > 3[mm] as a predictive value for the risk of surgical 
recurrence. 
 
Statistical analysis 
 
Predictive value were calculated for bowel wall thickness thresholds more or 
less than 3[mm]. Confidence interval (CI) was set at 95%, being statistical 
significance set at p value less than 0.05.  
All statistical analyses were performed using MedCalc software (MedCalc 
Software, version 9.2.1.0). 
 
3. Results 
 
Clinical characteristics of the study population are reported in Table I.  
Other data: 176 patients were clinically inactive (CDAI < 150 at the time of the 
bowel ultrasound); bowel ultrasound was performed after a mean time of 12 
months (range 6–15 months) after the resection.        
 
Table I  
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The average follow-up was 114 months (range: 25–205 months) after 
surgery. 
Major surgical complications occurred in 12 out of 196 patients (6%). 
Obviously, our final analysis refers to the reoperation for the disease recurrence 
and not to the reoperation for these immediate complications (Table II). 
 
Table II  
 
The rate of surgical recurrence for the whole population was 20.4% (40 
of 196 patients), at a mean distance of 78 months from previous surgery (range: 
20 months - 175 months). 
 
4. Discussion 
 
This is the largest retrospective study with the longest follow-up period in our 
knowledge. 
We think that knowing how many patients, 1 year after surgery, had a 
physiological bowel thickness (3[mm]) (50.5%) and how many had a 
pathological bowel thickness (> 3[mm]) (49.5%) is interesting in order to assess 
the entity of changes in the management of the subpopulation at greater risk of 
surgical recurrence (i.e. how many patients might be affected by a change of 
therapy to better their disease natural history) (Fig. 2). 
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Fig. 2. 
 
Patients with bowel wall thickness at the anastomosis > 3[mm] run a 
double relative risk (statistically significant) of undergoing surgery compared to 
patients with a thickness of 3[mm] (Table III). 
 
Table III 
 
The absolute incidence of new surgical intervention is 13% in patients with 
thickness of 3[mm], 28% in patients with thickness > 3[mm], 29,1% with 
thickness > 4[mm], 34% with thickness > 5[mm], 40% with thickness > 6[mm]. 
(Fig 3). 
 
Fig. 3. 
 
Although the population with a wall thickness > 3[mm] had taken steroids 
or immunosuppressants or biologics in a greater percentage (45% vs. 36%), it 
revealed a higher percentage of surgical recurrence (28% vs. 13%). The data 
suggest that these patients would have had an even more aggressive natural 
history of the disease if they had followed the same therapy as the population 
with a thickness ≤ 3[mm] (Fig. 4). 
 
Fig. 4. 
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Some critical issues should be considered. The retrospective design of 
the study represents a limitation and this is the reason because some patients 
were examined by ultrasound precociously and other late, but the same 
reasons are also the strength of the study: the “real world” setting of the data, 
the long follow-up period and the fact that all patients were treated in these 
years by the same doctor (A. M.). 
In conclusion, bowel wall thickness at the anastomosis > 3[mm] at bowel 
ultrasound performed 1 year after surgery could be added to the non-invasive 
predictors of early recurrence after ileo-colonic resection besides those implying 
a double risk of recurrence, such as smoking [13], previous bowel surgery, 
penetrating behavior of the disease, perianal location, extensive small bowel 
resection, absence of prophylactic treatment.  
A prospective study would be useful, in which the population with bowel wall 
thickness > 3[mm] 1 year after surgery would be treated with more aggressive 
drugs (topical or systemic steroids, immunosuppressants, biological agents), to 
investigate the possibility of bettering their disease natural history and extending 
their surgical recurrence-free interval. 
Ileocolonoscopy remains the gold standard in predicting recurrence. MR 
represent alternative tool for this indication; wireless capsule endoscopy appear 
promising, but it will require further investigation [3]. 
 
 
 
 
11 
 
5. References 
  [1]    Bernell O, Lapidus A, Hellers G. Risk factors for surgery and recurrence in 907 patients with primary    
          ileocaecal Crohn's disease. Br J Surg 2000;87:1697–701. 
  [2]    Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. et al. Predictability of the   
          postoperative course of Crohn's disease. Gastroenterology 1990;99:956–63. 
  [3]    Buisson A, Chevaux JB, Bommelaer G, Peyrin-Biroulet L. Diagnosis, prevention and treatment of   
          postoperative Crohn's disease recurrence. Dig Liver Dis 2012;44:453-60. 
  [4]    Castiglione F, deSio I, Cozzolino A, Rispo A, Manguso F, Del Vecchio Blanco Get al. Bowel wall  
          thickness at abdominal ultrasound and the one-year-risk of surgery in patients with Crohn’s disease.   
          Am J Gastroenterol 2004;99:1977-83. 
  [5]    Rigazio C, Ercole E, Laudi C, Daperno M, Lavagna A, Crocella Let al. Abdominal bowel ultrasound  
          can predict the risk of surgery in Crohn's disease: proposal of an ultrasonographic score. Scand J   
          Gastroenterol 2009;44:585-93. 
  [6]    DiCandio G, Mosca F, Campatelli A, Bianchini M, D'Elia F, Dellagiovampaola C. Sonographic   
          detection of postsurgical recurrence of Crohn disease. AJR Am J Roentgenol 1986;146:523-6. 
  [7]    Andreoli A, Cerro P, Falasco G, Giglio LA, Prantera C. Role of ultrasonography in the diagnosis of  
          postsurgical recurrence of Crohn's disease. Am J Gastroenterol 1998;93:1117-21. 
  [8]    Rispo A, Bucci L, Pesce G, Sabbatini F, de Palma GD, Grassia Ret al. Bowel sonography for the  
          diagnosis and grading of postsurgical recurrence of Crohn's disease. Inflamm Bowel Dis  
          2006;12:486-90. 
  [9]    Castiglione F, Bucci L, Pesce G, De Palma GD, Camera L, Cipolletta Fet al. Oral contrast-enhanced  
          sonography for the diagnosis and grading of postsurgical recurrence of Crohn's disease. Inflamm  
          Bowel Dis 2008;14:1240–5. 
[10]    Pallotta N, Giovannone M, Pezzotti P, Gigliozzi A, Barberani F, Piacentino Det al. Ultrasonographic  
          detection and assessment of the severity of Crohn's disease recurrence after ileal resection. BMC  
          Gastroenterol 2010;10:69. 
[11]    Parente F, Sampietro GM, Molteni M, Greco S, Anderloni A, Sposito Cet al. Behaviour of the bowel   
          wall during the first year after surgery is a strong predictor of symptomatic recurrence of Crohn's   
          disease: a prospective study. Aliment Pharmacol Ther 2004 Nov 1;20(9):959-68. 
[12]    Maconi G, Sampietro GM, Sartani A, Bianchi Porro G. Bowel ultrasound in Crohn's disease: surgical  
          perspective. Int J Colorectal Dis 2008 Apr;23:339-47. 
[13]    Bernstein C, Rawsthorne P, Cheang M, Blanchard JF. A population-based case control study of  
12 
 
          potential risk factors for IBD. Am J Gastroenterol 2006;101:993-1002. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
13 
 
Table I. Characteristics of the study population  
[n = 196 Crohn’s disease patients] 
Males/Females                                              115/81 
Median age, years (range)                    42 (16 – 82)  
Duration of Crohn’s disease, years (range) 
                                                                  8 (0 – 54) 
Smoking habit at surgery, n (%) 
   Ever smoker                                            86 (43.9) 
   Never smoker                                        110 (56.1) 
Previous surgery, n (%) 
   Never                                                     139 (70.9)  
   1                                                              41 (20.9) 
   2                                                                14 (7.1) 
   >2                                                                2 (1.0) 
Total length of bowel resection (cm) 
   < 50                                                    140 (71.4%) 
   >= 50                                                    56 (28.6%) 
Indications for surgery, n (%) 
   Strictures                                               103 (52.6) 
   Fistula                                                      54 (27.6) 
   Refractoriness to medical therapy           34 (17.3) 
   Perforation                                                   5 (2.6) 
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Table II. Major surgical complications 
Patients with major surgical complications    
                                                                     12 (6%) 
Complications: 
• anastomotic dehiscence                               10 
• entero-cutaneous fistula                                 1 
• hemorrhage                                                    1 
• occlusion                                                        1 
 Reoperation                                                         12 
# of patients with anastomosis wall thickness > 
3[mm] 1 year after operation 
                                                                     6 (50%) 
# of patients with surgical recurrence 
                                                                  5 (41.7%) 
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Table III. RR of surgical recurrence 
Wall thickness               RR  
> 3[mm]             2.1 (95% CI = 1.12 ÷ 3.74) 
> 4[mm]      2.0 (95% CI = 1.14 ÷ 3.49) 
> 5[mm]      2.2 (95% CI = 1.25 ÷ 3.70) 
> 6[mm]      2.5 (95% CI = 1.44 ÷ 4.24) 
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Fig. 1. Ileo-colonic anastomosis with wall thickening in both the ileal (↘) and 
colonic (│←) side  
Fig. 2. Thickness of the bowel wall at ultrasound performed 1 year after surgery. 
Fig. 3. Surgical recurrence rate.  
Fig. 4. Medications at the time of the bowel ultrasound. 
 
 
 
 
 
 
